{"id":166865,"date":"2014-12-15T05:54:30","date_gmt":"2014-12-15T10:54:30","guid":{"rendered":"http:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/uncategorized\/business-wire-the-1st-meeting-of-the-series-bridging-biomedical-worlds-turning-obstacles-into-opportunities-for.php"},"modified":"2014-12-15T05:54:30","modified_gmt":"2014-12-15T10:54:30","slug":"business-wire-the-1st-meeting-of-the-series-bridging-biomedical-worlds-turning-obstacles-into-opportunities-for","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/stem-cell-therapy\/business-wire-the-1st-meeting-of-the-series-bridging-biomedical-worlds-turning-obstacles-into-opportunities-for.php","title":{"rendered":"BUSINESS WIRE: The 1st Meeting of the Series Bridging Biomedical Worlds: Turning Obstacles into Opportunities for &#8230;"},"content":{"rendered":"<p><p>    MITTEILUNG UEBERMITTELT VON BUSINESS WIRE. FUER DEN INHALT IST    ALLEIN DAS BERICHTENDE UNTERNEHMEN VERANTWORTLICH.  <\/p>\n<p>    PARIS --(BUSINESS WIRE)-- 13.10.2014 --  <\/p>\n<p>    Stem cells hold great promise for treating a variety of human    diseases and injuries. Basic and translational stem cell    research is among the most competitive fields in the life    sciences. We have co-organized the first Bridging Biomedical    Worlds conference of our new series of international    scientific meetings: Turning Obstacles into Opportunities for    Stem Cell Therapy.  <\/p>\n<p>    The goal of this conference is to promote progress in the    translation of basic stem cell research into stem cell    therapies. To do this, presentations will highlight diverse    areas of on-going stem cell biology research. In addition,    panelists will discuss obstacles to translation and the    associated risks and ethical controversies. These panels will    provide a means to accelerate communication and cooperation    among researchers, bioengineers, clinicians and industry    scientists, and will explore ways to implement international    policies, regulations and guidelines to ensure the development    of safe and effective stem cell therapies worldwide.    Participants will hear about the latest basic and translational    stem cell research from more than 20 distinguished speakers    from China, Japan, Europe and theUnited States.  <\/p>\n<p>    This conference held in Beijing, China, October 13-15, 2014 is    co-organized by the Fondation IPSEN, AAAS\/Science and    AAAS\/Science Translational Medicine, in association    withFred Gage (Salk Institute for Biological Studies) and    Qi Zhou (Institute of Zoology, Chinese Academy of Sciences).  <\/p>\n<p>    About AAAS\/Science    The American Association for the Advancement of Science (AAAS)    is the worlds largest general scientific society and publisher    of the journal Science (www.sciencemag.org) as well as    Science Translational Medicine    (www.sciencetranslationalmedicine.org) and Science    Signaling (www.sciencesignaling.org). AAAS was founded in    1848, and includes some 261 affiliated societies and academies    of science, serving 10 million    individuals.Sciencehas the largest paid    circulation of any peer-reviewed general science journal in the    world, with an estimated total readership of 1 million. The    non-profit AAAS (www.aaas.org) is open to all and fulfills its    mission to advance science and serve society not only by    publishing the very best scientific research but also through    initiatives in science policy, international programs and    science education.    <a href=\"http:\/\/www.sciencemag.org\" rel=\"nofollow\">http:\/\/www.sciencemag.org<\/a>  <\/p>\n<p>    About AAAS\/Science Translational Medicine    Science Translational Medicine, launched in October    2009, is the newest journal published by AAAS\/Science.    The goal of Science Translational Medicineis to    promote human health by providing a forum for communicating the    latest biomedical research findings from basic, translational,    and clinical researchers from all established and emerging    disciplines relevant to medicine. Despite 50 years of advances    in our fundamental understanding of human biology and the    emergence of powerful new technologies, the translation of this    knowledge into effective new treatments and health measures has    been slow. This paradox illustrates the daunting complexity of    the challenges faced by translational researchers as they apply    the basic discoveries and experimental approaches of modern    science to the alleviation of human suffering. A major goal    ofScience Translational Medicineis to    publish papers that identify and fill the scientific knowledge    gaps at the junction of basic research and medical application    in order to accelerate the translation of scientific knowledge    into new methods for preventing, diagnosing and treating human    disease.    <a href=\"http:\/\/www.sciencetranslationalmedicine.org\" rel=\"nofollow\">http:\/\/www.sciencetranslationalmedicine.org<\/a>  <\/p>\n<p>    About the Institute of Zoology, Chinese Academy of    Sciences    Institute of Zoology (IOZ), Chinese Academy of Sciences (CAS),    is one of the leading research institutions in China. The    institute consists of 76 professors (including 2 members of    Chinese Academy of Sciences), 3 state key research laboratories    and 1 zoological museum. The major research areas of IOZ    include animal sciences, cell membrane biology, stem cells and    reproduction. The stem cell research teams of IOZ include over    10 PIs, and they mainly focus on questions related to the    establishment of pluripotent stem cell lines, neural stem cell    induction and regeneration, mechanism studies of pluripotency    and differentiation regulation of embryonic stem cells, animal    model establishment and functional studies, etc. The major    achievements in the field of stem cell research made by IOZ    faculties include: obtained the first healthy animal    (Xiaoxiao the mouse) using induced pluripotent stem cells    (iPSCs) via tetraploid complementation method, identified    molecular markers for the evaluation of pluripotency levels of    stem cells and the related regulatory mechanisms, achieved cell    fate conversion across different germ layers, established    various types of human and mouse embryonic stem cell lines, as    well as the Beijing Stem Cell Bank, etc. These achievements has    once been selected as one of the TIMES Top 10 Medical    Breakthroughs in 2009, and twice been selected as Top 10    Breakthroughs in Science and Technology in China. The Beijing    Stem Cell Bank now functions as a resource for stem cell and    regenerative medicine studies, providing various types of    embryonic stem cell lines, adult stem cell lines and somatic    cell lines for many research groups. IOZ also hosts modern    animal model research centers for pigs and monkeys, which have    generated a few valuable animal models for disease mechanism    studies and pharmaceutical researches.    <a href=\"http:\/\/www.english.ioz.cas.cn\" rel=\"nofollow\">http:\/\/www.english.ioz.cas.cn<\/a>  <\/p>\n<p>    About the Fondation Ipsen    Established in 1983 under the aegis of the Fondation de France,    the mission of the Fondation Ipsen is to contribute to the    development and dissemination of scientific knowledge. The    long-standing action of the Fondation Ipsen aims at fostering    the interaction between researchers and clinical practitioners,    which is essential due to the extreme specialization of these    professions. The ambition of the Fondation Ipsen is to initiate    a reflection about the major scientific issues of the    forthcoming years. It has developed an important international    network of scientific experts who meet regularly at meetings    known as Colloques Mdecine et Recherche, dedicated to    five main themes: Alzheimer's disease, neurosciences,    longevity, endocrinology and cancer science. Moreover the    Fondation Ipsen has started since 2007 several meetings in    partnership with the Salk Institute, the Karolinska Institutet,    the Massachusetts General Hospital, the Days of Molecular    Medicine Global Foundation as well as with the science journals    Nature, Cell and Science. The Fondation    Ipsen has published over one hundred books and has awarded more    than 250 prizes and research grants.    <a href=\"http:\/\/www.fondation-ipsen.org\" rel=\"nofollow\">http:\/\/www.fondation-ipsen.org<\/a>  <\/p>\n<p>    Fondation Ipsen    For further information, please contact:    Isabelle de Segonzac, Image Sept    E-mail : <a href=\"mailto:isegonzac@image7.fr\">isegonzac@image7.fr<\/a>    Tel. : +33 (0)1 53 70 74 70  <\/p>\n<p><!-- Auto Generated --><\/p>\n<p>The rest is here:<\/p>\n<p><a target=\"_blank\" href=\"http:\/\/rss.feedsportal.com\/c\/32337\/f\/442158\/s\/3f670d39\/sc\/27\/l\/0L0Sfinanztreff0Bde0Cnews0Cbusiness0Ewire0Ethe0E1st0Emeeting0Eof0Ethe0Eseries0Ebridging0Ebiomedical0Eworlds0Eturning0Eobstacles0Ei0C10A0A63812\/story01.htm\/RK=0\/RS=ys0YgdVbw9w_YJGZZ0YpS5q6nM8-\" title=\"BUSINESS WIRE: The 1st Meeting of the Series Bridging Biomedical Worlds: Turning Obstacles into Opportunities for ...\">BUSINESS WIRE: The 1st Meeting of the Series Bridging Biomedical Worlds: Turning Obstacles into Opportunities for ...<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> MITTEILUNG UEBERMITTELT VON BUSINESS WIRE.  <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/stem-cell-therapy\/business-wire-the-1st-meeting-of-the-series-bridging-biomedical-worlds-turning-obstacles-into-opportunities-for.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[25],"tags":[],"class_list":["post-166865","post","type-post","status-publish","format-standard","hentry","category-stem-cell-therapy"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/166865"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=166865"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/166865\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=166865"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=166865"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=166865"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}